Lisata Therapeutics Stock Market Value
| LSTA Stock | USD 2.58 0.15 5.49% |
| Symbol | Lisata |
Lisata Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lisata Therapeutics. If investors know Lisata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lisata Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.51) | Return On Assets (0.29) | Return On Equity (0.44) |
The market value of Lisata Therapeutics is measured differently than its book value, which is the value of Lisata that is recorded on the company's balance sheet. Investors also form their own opinion of Lisata Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Lisata Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lisata Therapeutics' market value can be influenced by many factors that don't directly affect Lisata Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lisata Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lisata Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lisata Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lisata Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lisata Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lisata Therapeutics.
| 12/28/2022 |
| 12/17/2024 |
If you would invest 0.00 in Lisata Therapeutics on December 28, 2022 and sell it all today you would earn a total of 0.00 from holding Lisata Therapeutics or generate 0.0% return on investment in Lisata Therapeutics over 720 days. Lisata Therapeutics is related to or competes with Lixte Biotechnology, Imunon, Rezolute, XOMA, Protagenic Therapeutics, Tempest Therapeutics, and Pulmatrix. Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellula... More
Lisata Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lisata Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lisata Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 19.57 | |||
| Value At Risk | (4.84) | |||
| Potential Upside | 6.53 |
Lisata Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lisata Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lisata Therapeutics' standard deviation. In reality, there are many statistical measures that can use Lisata Therapeutics historical prices to predict the future Lisata Therapeutics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | 0.462 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lisata Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lisata Therapeutics Backtested Returns
Lisata Therapeutics has Sharpe Ratio of -0.0542, which conveys that the firm had a -0.0542% return per unit of risk over the last 3 months. Lisata Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lisata Therapeutics' Mean Deviation of 2.17, risk adjusted performance of (0.03), and Standard Deviation of 3.19 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.42, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Lisata Therapeutics are expected to decrease at a much lower rate. During the bear market, Lisata Therapeutics is likely to outperform the market. At this point, Lisata Therapeutics has a negative expected return of -0.17%. Please make sure to verify Lisata Therapeutics' kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Lisata Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.34 |
Below average predictability
Lisata Therapeutics has below average predictability. Overlapping area represents the amount of predictability between Lisata Therapeutics time series from 28th of December 2022 to 23rd of December 2023 and 23rd of December 2023 to 17th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lisata Therapeutics price movement. The serial correlation of 0.34 indicates that nearly 34.0% of current Lisata Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.34 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Lisata Therapeutics lagged returns against current returns
Autocorrelation, which is Lisata Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lisata Therapeutics' stock expected returns. We can calculate the autocorrelation of Lisata Therapeutics returns to help us make a trade decision. For example, suppose you find that Lisata Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lisata Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lisata Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lisata Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lisata Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Lisata Therapeutics Lagged Returns
When evaluating Lisata Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lisata Therapeutics stock have on its future price. Lisata Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lisata Therapeutics autocorrelation shows the relationship between Lisata Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Lisata Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Lisata Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lisata Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lisata Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lisata Therapeutics Stock:Check out Lisata Therapeutics Correlation, Lisata Therapeutics Volatility and Lisata Therapeutics Alpha and Beta module to complement your research on Lisata Therapeutics. For information on how to trade Lisata Stock refer to our How to Trade Lisata Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Lisata Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.